Evaluating the Perception Among Rheumatologists of Maintenance of Board Certification in the US.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
03 2019
Historique:
received: 22 08 2018
accepted: 04 12 2018
pubmed: 21 12 2018
medline: 28 11 2019
entrez: 21 12 2018
Statut: ppublish

Résumé

There continues to be a debate about the value and purpose of maintenance of certification (MOC) programs in the US. The goal of this study is to assess the impact, value, and purpose of MOC programs in rheumatology. A survey was sent to 3,107 rheumatologists in the US. The survey addressed how rheumatologists perceive the value and impact of MOC programs on rheumatology practice and patient care. A total of 515 rheumatologists completed this survey. The majority (74.8%) believed there was no significant value in MOC, beyond what is already achieved from continuing medical education. Most rheumatologists did not believe MOC was valuable in improving patient care (63.5%), and the majority felt that the primary reason for creating MOC was either the financial well-being of board-certifying organizations (43.4%) or to satisfy administrative requirements in health systems (30%). Although 65.6% perceived that staying current with new medical knowledge was a positive impact of MOC programs, the MOC was perceived to result in time away from providing patient care (74.6%) and time away from family (74%). When asked about potential effects of requiring MOC, 77.7% reported physician burnout, 67.4% early physician retirement, and 63.9% anticipated an effect on reducing the overall number of practicing rheumatologists. The majority of rheumatologists do not believe there is significant value for MOC programs. There is evidence for lack of trust in board-certifying organizations, and rheumatologists believe MOC programs contribute to physician burnout, early retirement, and loss in the rheumatology workforce.

Identifiants

pubmed: 30570838
doi: 10.1002/acr.23823
pmc: PMC6692078
mid: NIHMS1044348
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

337-342

Subventions

Organisme : NIAID NIH HHS
ID : T32 AI007413
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2018, American College of Rheumatology.

Références

Mayo Clin Proc. 2016 Oct;91(10):1336-1345
pubmed: 27712632
Ann Intern Med. 2014 Aug 5;161(3):226-7
pubmed: 24821483
Ann Intern Med. 2015 Sep 15;163(6):401-8
pubmed: 26216046
N Engl J Med. 2012 Dec 27;367(26):2543-9
pubmed: 23268670
Arthritis Rheumatol. 2018 Jun;70(6):817-825
pubmed: 29399986
JAMA Intern Med. 2015 Jan;175(1):35-42
pubmed: 25365596
J Interv Card Electrophysiol. 2016 Oct;47(1):37-43
pubmed: 26956986
Arthritis Care Res (Hoboken). 2018 Apr;70(4):617-626
pubmed: 29400009
JAMA. 2014 Dec 10;312(22):2358-63
pubmed: 25490326
J Community Hosp Intern Med Perspect. 2013 Apr 17;3(1):
pubmed: 23882395

Auteurs

Amr H Sawalha (AH)

University of Michigan, Ann Arbor.

Patrick Coit (P)

University of Michigan, Ann Arbor.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH